Olivier Delattre

发表

Tatiana Popova, Emmanuel Barillot, Gudrun Schleiermacher, 2012, Acta Neuropsychiatrica.

SegAnnDB: interactive Web-based genomic segmentation

Francis R. Bach, Jean-Philippe Vert, Gudrun Schleiermacher, 2014, Bioinform..

MB-77MOLECULAR SUBGROUPING OF MEDULLOBLASTOMA WITH NANOSTRING TECHNOLOGY: A FEASIBILITY STUDY FOR ROUTINE REAL-TIME PROCEDURES.

Olivier Delattre, Franck Bourdeaut, Julien Masliah-Planchon, 2016 .

QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction

Emmanuel Barillot, Gudrun Schleiermacher, John M. Maris, 2018, Bioinform..

Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization

Emmanuel Barillot, Jean-Philippe Vert, Andrei Yu. Zinovyev, 2010, Bioinform..

Localizing potentially active post-transcriptional regulations in the Ewing's sarcoma gene regulatory network

Bernard Delyon, Ovidiu Radulescu, Anne Siegel, 2010, BMC Systems Biology.

VAMP: Visualization and analysis of array-CGH, transcriptome and other molecular profiles

Céline Rouveirol, Emmanuel Barillot, Nicolas Servant, 2006, Bioinform..

P53: Toward refinement of rhabdomyosarcoma classification by array CGH

Olivier Delattre, Gaëlle Pierron, Bénédicte Thuille, 2005 .

P23: CAP: a Web-based platform for CGH-array management and analysis

Céline Rouveirol, Eric Viara, Emmanuel Barillot, 2005 .

Learning smoothing models of copy number profiles using breakpoint annotations

Francis R. Bach, Jean-Philippe Vert, Gudrun Schleiermacher, 2013, BMC Bioinformatics.

SVDetect: a tool to identify genomic structural variations from paired-end and mate-pair sequencing data

Emmanuel Barillot, Isabelle Janoueix-Lerosey, Valentina Boeva, 2010, Bioinform..

Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

Frank Speleman, Rogier Versteeg, Isabelle Janoueix-Lerosey, 2010, Clinical Cancer Research.

Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis

Emmanuel Barillot, Gudrun Schleiermacher, Isabelle Janoueix-Lerosey, 2013, PloS one.

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

Gudrun Schleiermacher, Isabelle Janoueix-Lerosey, Olivier Delattre, 2008, Nature.

Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-β abolishes ewing sarcoma growth.

Olivier Delattre, Birgit Geoerger, D. Surdez, 2012, Cancer research.

Molecular profiling of patient-derived breast cancer xenografts

Anne Vincent-Salomon, Olivier Delattre, David Gentien, 2012, Breast Cancer Research.

Gene expression profiling of 1p35–36 genes in neuroblastoma

Gudrun Schleiermacher, Isabelle Janoueix-Lerosey, Olivier Delattre, 2004, Oncogene.

Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1

Olivier Delattre, J. Kappes, O. Delattre, 2001, Nature Medicine.

De novo motif identification improves the accuracy of predicting transcription factor binding sites in ChIP-Seq data analysis

Emmanuel Barillot, Olivier Delattre, Valentina Boeva, 2010, Nucleic acids research.

Beta‐catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics

Emmanuel Barillot, Christine Haberler, Pascale Varlet, 2009, The Journal of pathology.

A prognostic DNA signature for T1T2 node‐negative breast cancer patients

Anne Vincent-Salomon, Bernard Asselain, Olivier Delattre, 2010, Genes, chromosomes & cancer.

Cytogenetic prognostication within medulloblastoma subgroups.

Toshihiro Kumabe, Amar Gajjar, Andrey Korshunov, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.

Ruth Ladenstein, Gudrun Schleiermacher, Gian Paolo Tonini, 2009, The Lancet. Oncology.

Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas.

Olivier Delattre, Patrick Schöffski, Philippe Terrier, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

Olivier Delattre, Julian Lange, Alain Aurias, 1998, Nature.

Antagonism Pattern Detection between MicroRNA and Target Expression in Ewing’s Sarcoma

Andrei Zinovyev, Emmanuel Barillot, Loredana Martignetti, 2012, PloS one.

Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.

Isabelle Janoueix-Lerosey, Jean-François Michiels, Olivier Delattre, 2005, Cancer letters.

Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma at Single-Cell Resolution.

Andrei Zinovyev, Emmanuel Barillot, Jean-Philippe Vert, 2020, Cell reports.

ESR1 gene amplification in breast cancer: a common phenomenon?

Anne Vincent-Salomon, Olivier Delattre, Virginie Raynal, 2008, Nature Genetics.

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.

Roland Eils, Rainer König, Gary D Bader, 2014, Cancer cell.

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

Jean-Yves Delattre, Olivier Delattre, François Ducray, 2008, Molecular Cancer.

Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.

Li Ding, Xiaotu Ma, Jinghui Zhang, 2014, Cancer discovery.

Preferential Occurrence of Chromosome Breakpoints within Early Replicating Regions in Neuroblastoma

Emmanuel Barillot, Gudrun Schleiermacher, Philippe Hupé, 2005, Cell cycle.

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Roland Eils, Gudrun Schleiermacher, Barbara Hero, 2014, Clinical Cancer Research.

Coupled alteration of transcription and splicing by a single oncogene: Boosting the effect on cyclin D1 activity

Gabriel Sanchez, Olivier Delattre, Didier Auboeuf, 2008, Cell cycle.

Prognostic impact of gene expression-based classification for neuroblastoma.

Roland Eils, Lars Kaderali, Gudrun Schleiermacher, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma

Nathan C. Sheffield, Ruth Ladenstein, Christoph Bock, 2017, Nature Medicine.

Genomic Instability: A Stronger Prognostic Marker Than Proliferation for Early Stage Luminal Breast Carcinomas

Roman Rouzier, Anne Vincent-Salomon, Guillem Rigaill, 2013, PloS one.

Two types of chromosome 1p losses with opposite significance in gliomas

Olivier Delattre, Caroline Brennetot, Alain Aurias, 2005, Annals of neurology.

BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas

Emmanuel Barillot, Jean-Yves Delattre, Olivier Delattre, 2007, International journal of cancer.

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

Gudrun Schleiermacher, John M. Maris, Benedikt Brors, 2010, Clinical Cancer Research.

Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases.

Emmanuel Barillot, Philippe Hupé, Jérôme Couturier, 2009, Investigative ophthalmology & visual science.

Accumulation of segmental alterations determines progression in neuroblastoma.

Gudrun Schleiermacher, Jérôme Couturier, Isabelle Janoueix-Lerosey, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis

Andrei Zinovyev, Emmanuel Barillot, Gautier Stoll, 2013, Nucleic acids research.

Erratum: Protein interaction mapping: A Drosophila case study (Genome Research (2005) 15 (376-384))

Alain Vincent, Pierre Legrain, Bernard Jacq, 2005 .

Overall genomic pattern is a predictor of outcome in neuroblastoma.

Gudrun Schleiermacher, Frank Speleman, Jérôme Couturier, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia.

Olivier Delattre, Patrick Pauwels, Arjan W Griffioen, 2005, Cancer research.

Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma

Gudrun Schleiermacher, Olivier Delattre, David Gentien, 2016, Clinical Cancer Research.

Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas

Olivier Delattre, G. Thomas, O. Delattre, 1994, Nature Genetics.

PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.

Mauro Delorenzi, Jean-Paul Concordet, Olivier Delattre, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

Scott L. Pomeroy, Christine Haberler, Stefan M. Pfister, 2012, Acta Neuropathologica.

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials

Roman Rouzier, Etienne Rouleau, Nicolas Servant, 2015, Journal of the National Cancer Institute.

EWS, but Not EWS-FLI-1, Is Associated with Both TFIID and RNA Polymerase II: Interactions between Two Members of the TET Family, EWS and hTAFII68, and Subunits of TFIID and RNA Polymerase II Complexes

Olivier Delattre, Anne Bertolotti, Laszlo Tora, 1998, Molecular and Cellular Biology.

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Gudrun Schleiermacher, Jan Koster, Javed Khan, 2015, Nature Genetics.